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Abstract
Studies of schizotypal personality disorder (SPD) are important because the condition is genetically
related to schizophrenia and because data accumulating to confirm its biological underpinnings are
challenging some traditional views about the nature of personality disorders. This review of 17
structural imaging studies in SPD indicates that individuals with this disorder show brain
abnormalities in the superior temporal gyrus, parahippocampus, temporal horn region of the lateral
ventricles, corpus callosum, thalamus, and septum pellucidum, as well as in total cerebrospinal fluid
volume, similar to those seen in persons with schizophrenia. Differences between SPD and
schizophrenia include lack of abnormalities in the medial temporal lobes and lateral ventricles in
SPD. Whether the normal volume, and possibly normal functioning, of the medial temporal lobes in
individuals with SPD may help to suppress psychosis in this disorder remains an intriguing but still
unresolved question. Such speculation must be tempered due to a paucity of studies, and additional
work is needed to confirm these preliminary findings. The imaging findings do suggest, however,
that SPD probably represents a milder form of disease along the schizophrenia continuum. With
further clarification of the neuroanatomy of SPD, researchers may be able to identify which
neuroanatomical abnormalities are associated with the frank psychosis seen in schizophrenia.
Although schizophrenia was once considered the “graveyard of neuropathologists,”1 recent
neuroimaging techniques have radically changed this view. Early studies using computerized
tomography (CT) were pivotal in demonstrating ventricular abnormalities in the disorder but
did not provide the resolution required to document alterations in regions with unclear
boundaries such as the amygdala and various thalamic nuclei. With the advent of magnetic
resonance imaging (MRI), these latter brain regions of interest have been evaluated in
schizophrenia and found to be abnormal. In recent comprehensive reviews2,3 of MRI-
documented morphological brain abnormalities in schizophrenia, most brain regions studied
showed neuroanatomical alteration compared with the same regions in healthy controls.
Nonetheless, a convergence of findings suggested that the major locus for brain abnormalities
was the temporal lobe; fewer studies reported abnormalities in the lateral ventricles, prefrontal
cortex, inferior parietal cortex, basal ganglia, thalamus, corpus callosum, or septum
pellucidum.2,3 Note that, although many regions are involved in schizophrenia, they do not
appear to be equally affected, and the temporal lobe regions are the most severely altered. (For
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a recent review of MRI findings in schizophrenia and a discussion comparing the various brain
regions, see Shenton and colleagues.2)
In many cases, however, these MRI findings are difficult to interpret, given the possible
confounding effects of the chronicity of the psychotic illness and the medications used to treat
it. Although the definition of a personality disorder4 requires that a person experience distress,
the stress of chronic psychosis as seen in schizophrenia is arguably more relentless. McEwen
and Margarinos5 have demonstrated that increased stress-induced adrenal cortisol release,
along with excitatory amino acids, may result in atrophy of the hippocampal CA3 region. Such
atrophy may help to explain some of the medial temporal lobe findings in schizophrenia (see
section on temporal lobe structures, below).
Medications can also affect brain morphology. Chakos and colleagues6,7 compared the volume
of the basal ganglia in patients taking traditional and atypical antipsychotics and found that the
traditional antipsychotics increased caudate volume more than did the atypical medications.
Other possible effects of medication on brain morphology have been reported for superior
temporal gyrus volume.8 In addition, a recent animal model9 demonstrated increased volume
and glial density in the prefrontal cortex with chronic exposure to conventional neuroleptics.
The effect of anticholinergics, benzodiazepines, and anticonvulsants on specific brain regions
has been less extensively examined.
One way to avoid the possible confounding effects of medication is to study patients during a
first episode of schizophrenia, before they are treated with medications,10–15 as well as to
investigate at-risk populations,16 including first-degree relatives of individuals with
schizophrenia.17–23 An alternative approach is to study other populations presumed* to have
similar genetic vulnerability, such as patients with schizotypal personality disorder (SPD). Our
review will focus on CT and MRI structural imaging studies of persons with SPD.
SPD is characterized by difficulties with social interaction and language, together with odd
behavior and magical thinking. Because individuals with this disorder are not considered
psychotic, they have generally not been prescribed medications. Nonetheless, persons with
SPD and those with schizophrenia have a similar genetic predisposition, as suggested by
multiple family studies24,27–31 reporting that 6–7% of individuals diagnosed with
schizophrenia have a first-degree relative with SPD. Similarly, first-degree relatives of persons
with SPD have a 6.9% chance of developing schizophrenia.27
In an early epidemiological study conducted in Denmark, Kety and colleagues29 found that
the data supported the notion of a commonality between schizophrenia and schizophrenia-like
disorders, and they grouped these conditions into the “schizophrenia spectrum disorders.” This
work was followed by Kendler and colleagues’ Roscommon County family studies,27,30 which
further supported the spectrum concept and encouraged the use of other research tools to define
the phenotypic similarities between SPD and schizophrenia.
Other methodologies such as neurochemical analyses, behavioral studies, and
neuropsychological and evoked-potential measures have also shown abnormalities in SPD that
are similar to what has been demonstrated in schizophrenia.32 These include elevated
homovanillic acid levels,33,34 aberrant eye-tracking,35–38 reduced prepulse inhibition,39
cognitive deficits,40–43 and electrophysiological abnormalities.44–48 One hypothesis that
attempts to incorporate findings from these various methodologies has been proposed by Siever
(personal communication), who stated that the relative sparing in terms of symptoms and
*”Presumed,” since the underlying defective gene-gene interactions in schizophrenia have yet to be elucidated, although population
studies have supported the contention that schizophrenia and SPD share a common genetic diathesis (see below).24–28
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biological abnormalities in SPD compared with schizophrenia may be due to the fact that
hypodopaminergic function emanates from the basal ganglia and extends to the frontal lobes.
These projections may be “neuroprotective” to other regions such as the frontal lobes.32,49
Structural MRI studies of the basal ganglia and frontal lobes as well as functional studies
examining dopaminergic function are needed to test this hypothesis further.
Another impetus for studying SPD, in addition to the disorder’s close genetic and biological
ties with schizophrenia, is the importance of such research for the conceptualization of
personality disorders. More specifically, personality disorders have traditionally not been
thought to have a neurological basis. Now a wealth of data from multiple sources is radically
challenging this view (see the studies cited in the previous paragraph). Moreover, with the
neuroanatomical basis of SPD becoming more clearly established, investigations of the
biological underpinnings of SPD may be a useful model to apply to other personality disorders.
The critical question that we ask, and seek to answer, in this review is: Do the imaging data
support the notion that SPD is a less severe version of schizophrenia, or is it a distinct disorder?
If the former, might we expect that persons with SPD will have fewer neuroanatomical
abnormalities, and therefore less-severe clinical symptoms, than do individuals with
schizophrenia? If the data support the idea that SPD is a less penetrant form of schizophrenia,
then the next question concerns what abnormalities are present in schizophrenia but absent in
SPD. Answers to this last question need to be examined in future studies and may help to direct
attention to strategies for preventing the development of schizophrenia.
We performed a Medline search in February 2001 for English-language articles including the
key words schizotypal personality disorder, schizophrenia, relatives, computerized
tomography, and magnetic resonance imaging. We found and reviewed 17 studies. We began
with investigations in which subjects met full DSM criteria for SPD, then continued with
studies in which subjects had some of the features of SPD but did not meet the full criteria,
reports of children with symptoms consistent with SPD, and finally other studies (i.e., reports
of persons with SPD and schizophrenia analyzed together, or of individuals with SPD who
have family members with schizophrenia). This organization reflects the different strategies
used by researchers to enlist subjects with SPD for their studies. Such strategies include
recruiting families of probands with schizophrenia, recruiting patients from clinics, recruiting
community dwellers by means of newspaper advertisements, and recruiting college students
who score high on scales of psychopathology thought to tap cognitive manifestations of SPD.
Diagnostic criteria have also differed and range from meeting five out of the nine required
DSM-IV criteria, to having some features of schizotypy derived by diagnostic impression
during clinical interview, to scoring high on scales of psychopathology.
We included all 17 studies in our review, even though some included very few patients with
SPD or SPD-like pathology. Table 1 provides a summary of these studies.
OVERVIEW
Two important changes have occurred over time in brain morphology studies of individuals
with SPD. First, CT techniques have gradually given way to MRI, which has allowed the
investigation of more regions and with finer neuroanatomical resolution (including
differentiation between gray and white matter). Second, researchers have gone from examining
subjects with some features of schizotypy to studying persons determined through
semistructured interviews to meet full DSM criteria for SPD. This change can been seen in
Table 1, where it is clear that the majority of recent studies use MRI and involve subjects
meeting full criteria for SPD.
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All eight of the MRI studies that analyzed the data for subjects with full criteria separately have
emanated from two centers, Mt. Sinai School of Medicine49–52 and Harvard Medical School.
53–55 (Note that in 1992 and 1994 researchers from the University of Pennsylvania56,57 used
CT to examine a cohort of subjects who met full criteria for SPD, considered under the category
of subjects at high risk for schizophrenia [all had mothers with the disorder].) This illustrates
not only the difficulty in recruiting this important subject population but also the fact that
different laboratories employ different approaches for understanding the intrinsic
morphological abnormalities of the brain found in the schizophrenia spectrum disorders.
Importantly, however, nine of the 17 studies were published since 1998, suggesting a marked
increase in interest in this topic.
STUDIES OF SUBJECTS WHO MEET FULL CRITERIA FOR A DIAGNOSIS OF
SPD
Two laboratories investigating SPD have used individuals who meet full DSM criteria for the
diagnosis of SPD. The two laboratories have employed distinctly different recruitment
procedures, however. The first laboratory, at Mt. Sinai School of Medicine, has recruited its
subjects from local inpatient and outpatient units. Some of these individuals have received
medications, including neuroleptics. Our laboratory at Harvard Medical School and the
Veterans Affairs Boston Healthcare System, by contrast, has recruited subjects from the
community by means of newspaper ads and posted fliers so as to avoid the potential
confounding effects of medication. The use of such disparate approaches may have resulted in
the sampling of quite different populations. This fact, plus differences between the clinical
assessment protocols in the two laboratories, makes direct comparisons between the study
populations difficult. The Mt. Sinai cohort, for example, may include subjects with either more-
serious symptoms or a greater proportion of positive symptoms, leading them to attend a clinic
and be prescribed neuroleptic medications; our cohort may include subjects with a greater
proportion of negative symptoms, or with fewer or more-attenuated symptoms. All of this is
conjecture, however, since neither group has reported measures of positive and negative
symptoms. In addition, neither group of researchers has discussed the potential issue of high
Axis I and Axis II comorbidity, which has been described by McGlashan.58 This may be an
important focus for future work on the biological basis of SPD. These different approaches
may be complementary in that they may help to elucidate how clinical features affect brain
morphology. Note that, as with other studies included in this review, the number of subjects
studied in these laboratories is limited, and within a laboratory, samples have partially
overlapped. This reflects the difficulties inherent in recruiting subjects with SPD. However,
since researchers are just beginning to understand the neuroanatomy of SPD, extensive study
of various brain regions in a limited number of subjects may be a prudent approach.
Below, we review findings from Mt. Sinai on the thalamus and corpus callosum. We then
review findings from our laboratory on cerebrospinal fluid (CSF), gray and white matter,
temporal lobe structures, and the cavum septi pellucidi, and finally the findings from both
laboratories on the lateral ventricles.
Mount Sinai Group: Clinic-Based Studies
Thalamus—The thalamus is the major relay station of the brain; it consists of multiple nuclei
and their connections to cortical regions (i.e., mediodorsal nuclei with the prefrontal cortex,
and anterior and midline nuclei with limbic and paralimbic structures59). Due to these
interconnections, the thalamus is considered by some to be key to the understanding of
schizophrenia.60
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The first study of thalamic volume in subjects with SPD, conducted by Hazlett and colleagues,
51 showed no differences in thalamic volume or thalamus:brain ratio between patients with
SPD and controls but did show differences in shape. Patients with SPD had fewer pixels in the
right mediodorsal nucleus and patients with schizophrenia had fewer pixels in the left anterior
region than did controls. In a second component of the study, the investigators determined with
positron emission tomography that patients with schizophrenia had diminished metabolism in
the mediodorsal nucleus bilaterally compared with SPD patients and comparison subjects.
To refine these findings further, Byne and colleagues52 examined the pulvinar and mediodorsal
nuclei of the thalamus in a subset of the subjects. They reported that, compared with controls,
both the patients with SPD and those with schizophrenia had reduced pulvinar nuclei, but the
patients with schizophrenia had the additional abnormality of reduced mediodorsal nuclei.
Various subdivisions of the pulvinar are involved in relaying sensory inputs to primary visual
and auditory sensory areas,59 to the prefrontal cortex,52 and to the temporoparietal heteromodal
association cortex.52,61 There are a few reports of damage to this region resulting in language
disturbances.51,60 Thus, these nuclei may be critically involved in the processing and
integration of visual and auditory information, and damage could hypothetically result in
misperceptions.
Taken together, these results suggest that frontolimbic/thalamic connectivity may be different
in SPD than in schizophrenia, and this may, in part, contribute to the differences in the clinical
symptoms in the two disorders. Such a possibility is particularly interesting, given the current
interest in thalamic connections and, as proposed by Andreasen and others,60 their possible
central role in the production of these conditions.
Corpus callosum—The corpus callosum is the major interhemispheric fiber pathway. One
of the theories of the etiology of schizophrenia62 involves a failure of interhemispheric
communication. As a result, the corpus callosum has been the subject of 27 investigations; 17
of these have reported abnormalities.2 In the only study to examine corpus area and shape in
SPD, Downhill and colleagues49 reported that the genu of the corpus was larger in patients
with SPD than in those with schizophrenia or control subjects, whereas the posterior corpus
was largest in controls, second largest in patients with SPD, and smallest in patients with
schizophrenia. (The difference in the latter measure between SPD patients and schizophrenia
patients was not statistically significant, however.) Furthermore, these investigators found that
the shape differences were consistent with the differences in corpus area. They concluded that
these area and shape abnormalities of the corpus may lead to poor interhemispheric
connectivity and could be responsible for the improper reality testing found in the
schizophrenia spectrum disorders.
Our Laboratory: Community-Based Studies
CSF, gray, and white matter—In many studies of patients with schizophrenia, there
appears to be an abundance of CSF, whether measured in the ventricles, in the sulci, or as total
CSF volume.2,3 In our sample of individuals with SPD, we demonstrated increased CSF
volume that was not attributable to lateral ventricle enlargement. We also examined total gray
matter volume and found no difference between persons with SPD and normal controls.
However, when the cortical gray matter was more carefully delineated with the elimination of
the subcortical structures and the cerebellum, we found a trend toward reduced cortical gray
matter in persons with SPD compared with controls.55 We found no difference in white matter
between the two groups.
Temporal lobe structures—Interest in temporal lobe structures in schizophrenia stems
from the critical role of these structures in language and auditory processing and the observation
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that language abnormalities and auditory hallucinations are among the hallmarks of this
disorder. Of note, many independent research laboratories investigating schizophrenia have
reported abnormalities in temporal lobe structures,2,3,63–67 including the superior temporal
gyrus (STG), parahippocampal gyrus, and amygdala-hippocampal complex. The volumes in
these regions have also been correlated with cognitive and clinical symptoms including formal
thought disorder and auditory hallucinations, as well as with verbal memory problems.62,68
The amygdala, more specifically, may be involved in the attaching of emotional relevance,
particularly to visual stimuli including emotional facial expressions;69 in general arousal and
other basic functions including sleep, feeding, and sexual activities;68 and in memory.68
Our own laboratory70 has reported reductions in gray matter volume in the STG, amygdala,
hippocampus, and parahippocampal gyrus in persons with schizophrenia, and we have
extended this work to patients with first-episode psychosis71 and individuals with SPD. We
applied the methodology of our previous studies in schizophrenia to a group of individuals
with SPD recruited from the community by means of newspaper advertisements. We predicted
that we would see similar, but more-attenuated, volume reduction in the subjects with SPD.
We found such subjects to have selective reduction of the left STG gray matter and
parahippocampal asymmetry.54 In an attempt to refine the STG results, we examined two of
its main components, Heschl’s gyrus and the planum temporale,72 and found the former to be
reduced. In addition, we found that subjects with SPD exhibited formal thought disorder.54
This was intriguing, since reduced STG gray matter is one of the most robust findings in
schizophrenia (all of the 12 studies examining this found volume reduction2), and
parahippocampal asymmetry has been shown postmortem to be abnormal in persons with
schizophrenia.73 This study demonstrating partial—but not complete—replication suggested
that perhaps, at least in this region, there is a relationship between volume affected and clinical
severity.
Cavum septi pellucidi—The septum pellucidum is a membrane formed in utero by two
leaflets that fuse secondary to pressure of the growing hippocampus and corpus callosum.
Space remaining when the closure is incomplete is termed “cavum septi pellucidi”; such a
space is seen in 15% of healthy controls52 at 6 months.53 The presence of a large cavum septi
pellucidi has been noted in schizophrenia (11 out of 12 studies reported abnormalities).2 One
study53 has examined this neurodevelopmental abnormality in patients with SPD, and it found
a prevalence of 27%. These data suggest that SPD and schizophrenia probably have a
neurodevelopmental component to their etiology.
Clinic- and Community-Based Studies: Lateral Ventricle Findings
The two laboratories have each examined the lateral ventricles in patients with SPD. They
produced slightly different results in the anterior and temporal horns, possibly due to different
demographic variables.
Historically, enlarged lateral ventricles have been one of the most common findings in the
schizophrenia literature: 78% of the 55 MRI2 studies (as well as 75% of the CT studies2)
examining this region showed larger lateral ventricles in persons with schizophrenia than in
controls. However, neither the Mt. Sinai group (first with CT74 and then with MRI50) nor our
group55 has found a statistically significant difference in total lateral ventricle volume between
individuals with SPD and controls. Thus, in this region there appears to be a difference between
schizophrenia and SPD: persons with SPD are less affected than are those with schizophrenia.
Subtle differences may exist between persons with SPD and healthy controls in particular
regions of the lateral ventricles, however. In an evaluation of clinic-based SPD patients at Mt.
Sinai, Buchsbaum and coworkers50 reported that the left anterior and temporal horns in these
individuals were larger than those in age- and sex-matched normal controls but significantly
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smaller than those in patients with chronic schizophrenia. This contrasts with what our
laboratory has shown in our community-based sample, in which we reported no difference.
55 Therefore, although both groups report no statistically significant difference between
persons with SPD and controls, the Mt. Sinai study included the additional feature of comparing
such volumes with those of schizophrenia patients and demonstrated a continuum among the
three groups on this measure.
These two studies were similar in that they both involved subjects meeting full criteria for SPD,
but they differed in demographic variables. Left- and right-handed males and females were
included in Buchsbaum and colleagues’ investigation,50 whereas only right-handed males were
included in Dickey and coworkers’ study.55 Perhaps the greatest difference in the samples,
however, results from the method of recruitment—clinic versus community. Subjects in a
clinic-based sample may have more-severe SPD symptoms than do those in a community-
based one; they may also have fewer negative symptoms such as social anxiety. The issue of
high Axis I and Axis II comorbidity, which has been described in SPD58 but is not addressed
in these publications, may also be important in deciphering the findings. In addition,
pharmacological treatment of SPD patients could be playing a role in clinic-based samples.
These variables may be key in understanding the subtle differences in the findings concerning
the anterior and temporal horns.
In summary, these two MRI studies of subjects who met full criteria for SPD did not show
enlarged lateral ventricles. This may suggest that in individuals with pure SPD this region is
spared the abnormalities typically seen in persons with schizophrenia. Subsequent studies to
examine the lateral ventricles either have analyzed SPD patients together with schizophrenia
patients or have not used subjects clearly diagnosed with SPD (see below). One tentative
conclusion, therefore, is that enlargement of the lateral ventricles is not a feature of SPD, and
the presence of enlarged ventricles in schizophrenia may be a morphological index of clinical
severity.
OTHER STUDIES
Studies of Subjects with Schizotypal Features Who Meet Some but Not All Criteria for a
Diagnosis of SPD: Frontotemporal Area
One approach to understanding the schizophrenia spectrum disorders is to study individuals
who do not meet criteria for a particular disorder but who nonetheless have some of the features
of that disorder. This approach is best exemplified by Raine and coworkers,75 who examined
17 subjects who scored high on scales of schizotypal features but were not assessed using DSM
criteria. These individuals were employees of local hospitals and other work settings. Excluded
from the pool of perspective subjects were physicians and other workers expected to have high
social class and a high level of education. In this study high degrees of schizotypy were found
to be significantly associated with reduced left prefrontal area and with left and right
prefrontal:temporal area ratios. The prefrontal cortex is involved in impulse inhibition,
assessing the behavioral relevance of stimuli, using working memory while shifting sets,
making judgments, and planning. It has vast interconnections with most other sections of the
cortex and can influence the activation or de-activation of those areas.59 Unfortunately, the
imaging protocol was performed on a machine with low magnetic field strength (0.15 T, as
opposed to the 1.5 T often used), and only one slice was used to determine prefrontal and
temporal areas for each subject. Nonetheless, this early study suggested that persons with some
schizotypal features may have aberrations in the prefrontal and temporal cortices— areas that
have been shown to be abnormal in individuals with schizophrenia.
An excess of schizotypal traits in subjects with a sex chromosome aneuploidy (SCA) was
documented in a recent thesis.76 To follow up on this observation, Warwick and
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colleagues77 studied individuals with SCA and some features of schizotypy. Using MRI to
examine multiple brain regions including the prefrontal cortex, they detected no abnormalities.
Unfortunately, data for the subjects with SCA and many features of schizotypy were not
analyzed separately from data for those with SCA alone.
Given the paucity of prefrontal studies examining subjects who have been clearly diagnosed
with SPD, no firm conclusions can be drawn for this brain region.
A Study of Children at Risk for Developing SPD or Schizophrenia: Amygdala, Temporal
Cortex, and Corpus Callosum
In the only relevant study of children, Hendren and colleagues78 reported that 8- to 12-year-
olds with symptoms of either SPD or schizophrenia showed reduced amygdala and temporal
cortex volumes and reduced corpus callosum area, similar to what has been shown in
schizophrenia.2,3 The authors suggested that the occurrence of abnormalities at a young age is
the result of genetic or environmental events occurring in utero and altering neurodevelopment;
they did not explore other possible etiologies, such as postnatal stress. Hendren and coworkers
did not demonstrate enlarged lateral ventricles, as has been shown in subjects meeting full
criteria for SPD.50,55 Instead, they hypothesized that enlarged ventricular volume may
represent disease progression in schizophrenia, a speculation shared by others,79,80 but because
the study was cross sectional, their data did not address that issue directly. Due to the
subjects’young age, the investigators were unable to make definitive distinctions between SPD
and schizophrenia, so subject groups were not analyzed separately. As suggested by the authors,
it will be interesting to follow these children and retrospectively review their scans to determine
whether the children who subsequently developed SPD had quantitatively fewer abnormalities
than did those who subsequently developed schizophrenia.
A Study Analyzing Patients with SPD and Those with Schizophrenia Together: Ventricles
In a hospital-based study of patients with SPD or schizophrenia who also had prodromal
symptoms of obsessive-compulsive disorder (OCD), persons with nonpsychotic OCD, and
normal controls, Kurokawa and coworkers81 examined MRIs to determine whether the
presence of enlarged ventricles might promote the early detection of SPD or schizophrenia in
persons who early in the course of the illness show symptoms of OCD. They found that the
patients who had developed SPD or schizophrenia had larger ventricles than did those with
OCD alone. They concluded that patients with OCD symptoms and enlarged ventricles on MRI
may be at risk for later developing one of the schizophrenia spectrum disorders. They did not
analyze data for the SPD patients separately, however, probably due to the small sample size
(n = 4). Conclusions about ventricular size in SPD cannot be drawn from this study, since the
subjects with schizophrenia may have been driving the findings.
Studies of Patients with SPD Who Have First-Degree Relatives with Schizophrenia:
Ventricles
The Mt. Sinai group, in search of genetic markers common to schizophrenia spectrum
disorders, has studied family pedigrees of probands with schizophrenia. Within these families,
some members have been affected by SPD. Shihabuddin and colleagues82 studied a family
with the linkage marker for such disorders on the short arm of chromosome 5(5p14.1–13.1).
Eleven family members (of whom three had schizophrenia and two had SPD) underwent CT
to determine whether there was a relationship between the presence of the marker and brain
abnormalities. All of the affected members and one unaffected member carried the marker
allele. These six individuals had enlarged lateral ventricles and an enlarged ventricle:brain ratio
(VBR), whereas the remaining unaffected members did not.
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Silverman and colleagues83 have shown increased VBR in persons with SPD or schizophrenia
in a larger group of families. In this study, however, the researchers lumped the individuals
with SPD together with family members who had four of nine criteria for the disorder but not
full-blown SPD. How the persons with full criteria differed from those with partial criteria was
not detailed. Nonetheless, the investigation suggested a relationship between the genetic
loading and brain structure.
Prior to the publication of DSM-III, persons with features consistent with SPD (for example,
subtle thought disorder, social isolation, magical thinking) were classified as having borderline
schizophrenia.84 Today, many of these subjects would be reclassified by DSM-IV criteria as
having SPD. In an early CT study of offspring of mothers with schizophrenia, Schulsinger and
coworkers84 found that the offspring with schizophrenia had enlarged third ventricles and an
increased VBR, whereas the mentally healthy offspring had normal ventricles, and those with
borderline schizophrenia had the smallest ventricles. This is the only study in our review that
reported smaller ventricles in subjects with an SPD-like disorder than in controls. In addition,
the offspring with schizophrenia had experienced more obstetrical complications than had
either of the other two groups. These authors84 suggested the “diathesis-stress” model for
interpreting the data—that is, that “schizophrenia is the result of deleterious environmental
influences acting on a genetic predisposition.”
In a second CT study of offspring of mothers with schizophrenia, Cannon and colleagues57
found that the offspring suffering from SPD or schizophrenia had enlarged sulci, but only those
with schizophrenia had enlarged ventricles. (The study also included offspring of unaffected
mothers. Some of these offspring had psychiatric disorders, and some did not. The four
offspring with SPD who had unaffected mothers were not analyzed separately.) These
researchers concluded that the offspring with the more-severe disorder, schizophrenia, had
more morphological abnormalities (sulcal and ventricular enlargement), whereas those with
SPD had sulcal enlargement alone. Previously these researchers56 had demonstrated that
offspring of mothers with schizophrenia (healthy, with SPD, or with schizophrenia) had
enlarged third ventricles, but unfortunately they did not perform analyses comparing the three
groups.
DISCUSSION
It is difficult to reach conclusions from such a limited number of studies composed of small
sample sizes and subjects with disparate characteristics. Nonetheless, from studies with
subjects who meet full criteria for SPD, it appears that individuals with SPD may have reduced
gray matter of the superior temporal gyrus, asymmetry of the parahippocampus, abnormalities
in thalamic shape and pulvinar volume, larger sulci, abnormalities in the shape of the corpus
callosum, and a high prevalence of large cavum septi pellucidi. Each of these potential
abnormalities has been well documented in schizophrenia.2,3 In most of the studies, however,
the subjects with SPD do not have all of the abnormalities that might be present in
schizophrenia. For example, persons with SPD have reduced superior temporal gyrus volumes
and parahippocampal asymmetry but not the frank parahippocampal volume differences or
differences in other medial temporal lobe structures such as the hippocampus and amygdala
that are found in schizophrenia (see above). Also, from the studies done to date, lateral
ventricles appear to be normal.
The specific pathogenesis of these morphometric alterations in SPD cannot be determined from
the studies reviewed. For example, one cannot deduce whether the abnormalities are a direct
result of neurodevelopmental genetic programing, whether they are a result of distal
abnormalities causing deafferentation, or whether they represent a decrease in interneurons.
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Byne and colleagues,52 in their discussion of thalamic abnormalities, proposed the possibility
of different etiologies for different nuclei within the thalamus.
To determine whether the additional regions affected in schizophrenia are critical for the
production of frank psychosis (i.e., whether they are also present in affective disorder with
psychosis) or are inherent to schizophrenia, data from our laboratory comparing affective
disorder with psychosis is informative. Table 2, a comparison among SPD, first-episode
schizophrenia, and first-episode psychotic affective disorder,71 shows that the development of
psychosis may require abnormalities in the medial temporal lobe structures. This is in contrast
to the involvement of the superior temporal gyrus, the increase in sulcal CSF, and the decrease
in cortical gray matter found in both SPD and schizophrenia, but not in first-episode psychosis.
These patterns of abnormalities suggest that the superior temporal gyrus may be critical in the
schizophrenia spectrum disorders.
To return to our earlier question of whether SPD should be considered a distinct disorder or a
subset of schizophrenia, we believe that the CT and MRI data produced so far cannot fully
separate the two conditions. To date, there has been no definitive report of an SPD abnormality
that has not been shown in schizophrenia.† In fact, one of the strategies of SPD research is to
examine brain regions that have been found to be abnormal in schizophrenia to determine
whether they may represent abnormalities fundamental to the schizophrenia spectrum disorders
or to psychosis. Once other brain regions are examined, additional abnormalities may be found.
However, based on the available literature, one can conclude that not all the abnormalities
found in schizophrenia are found in SPD. For example, medial temporal lobe structures are
normal in SPD.54 Therefore, SPD may be considered to represent an attenuated form of
schizophrenia.
The implication of these findings is that individuals with SPD are comparatively spared in
some brain regions while those with schizophrenia are relatively afflicted, despite possibly
similar genetic diatheses. It may be, however, that this genetic continuum can result in some
subjects having more of a critical genetic load and others having less. Additionally, subtle in
utero differences such as lower incidence of exposure to influenza virus—or less stress-induced
steroid release—in persons with SPD than in those with schizophrenia may account for the
differences in the development of the two disorders. Finally, as these individuals age, repeated
environmental stressors may have an additional impact on the progression of both SPD and
schizophrenia. How sparing or affliction occurs is critical to determine in future studies.
We believe that SPD represents part of the continuum of clinical symptoms observed in the
schizophrenia spectrum and involves some of the same morphological abnormalities.
Conservatively speaking, however, the available CT and MRI data cannot rule out the
possibility that SPD is a distinct disorder, although this possibility seems unlikely. One primary
strategy of SPD research is to examine brain regions that have been found to be abnormal in
schizophrenia to determine whether or not they are also observed in SPD or are a nonspecific
concomitant of psychosis. One example of the separation between SPD and psychosis is
demonstrated by the finding that medial temporal lobe structures (the amygdala and
hippocampus) are abnormal in first-episode schizophrenia and in first-episode psychosis71 but
not in SPD.54
†There are two possible exceptions. Downhill and colleagues49 reported corpus callosum shape differences in certain regions in persons
with SPD. The corpus has been shown to be abnormal in schizophrenia,2 although perhaps in slightly different regions. Also, Hazlett
and colleagues51 found fewer pixels in the region of the right mediodorsal nucleus in patients with SPD than in those with schizophrenia
or normal controls.
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Clearly more studies are necessary to investigate the neuroanatomy of SPD. Persons who meet
full criteria for SPD need to be evaluated, and this population, although difficult to tap, is
important to our understanding of which brain abnormalities are inherent to the schizophrenia
spectrum and which are due to the ravages of schizophrenia and its treatments—or perhaps to
other prenatal or environmental stresses. The relationship among genetic load, pre- and
postnatal environmental factors, and morphological abnormalities in the development of
schizophrenia is far from clear. Nonetheless, understanding the interaction of these factors is
critical for understanding the pathogenesis of schizophrenia and potential avenues for
intervention.
This review focused on CT and structural MRI findings in SPD. Morphological studies can
describe volumes, shapes, and anatomical patterns but cannot address the critical question of
the functional capacity of the structures. To date, no functional MRI (fMRI) studies of SPD
have been published. As more laboratories move toward fMRI and begin to elucidate the
functional anatomy of this disorder, it will be important to discover how individuals with SPD
differ from those with schizophrenia in the realms of attention, language processing, and
emotional processing/expression, where some of the core abnormalities in the schizophrenia
spectrum are seen. This complementary coupling of morphometric and functional studies can
then begin to address the relationship between anatomy and clinical phenomena. For example,
if one believes that magical ideation and certain delusions represent clinical phenomena along
a continuum of severity, then fMRI experiments involving subjects with SPD or schizophrenia
who are experiencing magical ideation or delusions, respectively, may help to sort out the
anatomy involved in those two phenomena. Such an experiment may point to specific areas of
functional impairment in the brains of these individuals. However, interpreting findings of a
reduced fMRI signal is difficult without knowing underlying structural volumes. In addition,
understanding how persons with a schizophrenia spectrum disorder process information may
be invaluable for family members coping with these devastating conditions.
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TABLE 1
Morphological Studies of SPD
Study Subjects Regions examined/measures Findings Comments
Schulsinger et al.84 33 offspring of
mothers with SZ (11
with borderline SZ
[probably SPD], 8
with SZ, 14 mentally
healthy)
Lateral ventricle, third ventricle,
VBR





SZ had the smallest
CT study; each measurement
performed on 1 slice. Subjects with
borderline SZ had fewer obstetrical
complications than did those with
SZ.
Cannon et al.57 34 offspring of
mothers with SZ (12
with SPD, 7 with SZ,
15 unaffected)
Maximum width of sylvian
fissure, width of anterior
interhemi spheric fissure, mean
width of 3 broadest cortical sulci,






with lower heart rate
18 y previously
CT study; each measurement
performed on 1 slice, sometimes
using calipers. Sample overlaps
with Schulsinger et al.84 Authors
also measured heart rate on
enrollment in the study, 18 y
previously. The 3 groups were not
compared on CT measures.
Raine et al.75 17 with schizotypal
features, but not SPD








MRI study, 0.15-T magnet; 12
slices, 10 mm thick, with single
slices used for measures of
prefrontal and temporal cortex
Cannon et al.57 126 offspring of
mothers with SZ (31
with SPD, 17 with
SZ, 33 with another
diagnosis, 45 with no
diagnosis) and 77
offspring of NC
mothers (1 with SZ, 4
with SPD, 26 with
another diagnosis, 46
with no diagnosis)
Ventricles and sulci, VBR,
sulcus:brain ratio, temporal and
frontal fissures, lateral ventricles
Offspring of mothers
with SZ who had SZ
or SPD showed larger
sulci than did any
other group; offspring
of mothers with SZ
who had SZ had larger
ventricles than did
any other group
CT study; 13 slices, 8 mm thick.
The sample overlaps in part with
those of Schulsinger et al.84 and
Cannon et al.56
Hendren et al.78 25 children aged 8–
12 y (12 with
symptoms of SPD or
early-onset SZ, 13
NCs
Amygdala, hippocampus, part of
temporal cortex (slices on which
amygdala and hippocampus
could be visualized), corpus
callosum area, cerebellum area,
frontal lobe area (on midsagittal
slice), lateral ventricle, third
ventricle, temporal horn
Children with





MRI study, 1.5-T magnet; area
measures were performed on 1
slice. MRS data were also reported
for 9 subjects and 8 controls. Poor
complex verbal memory was seen
in children with symptoms of SPD
or SZ.




VBR, frontal and posterior horns
of lateral ventricle, third
ventricle
VBRs of subjects with
SPD were higher than






of NCs and those of
subjects with SZ
CT study (2 different scanners
used); slices 0.8–1.0 cm thick,
depending on scanner. Some of the
subjects with SPD had been
exposed to neuroleptics.
Shihabuddin et al.82 11 individuals from a
single pedigree (2
with SPD, 3 with SZ,
6 unaffected)
Lateral ventricles, VBR, anterior
horn, temporal horn, measure of
sulcal CSF by brain region
Affected subjects plus
1 unaffected subject





larger CSF volumes in
frontal and parietal
regions than did the 5
subjects not carrying
the marker
CT study; slices 8 mm thick. Data
for subjects with SPD were not
analyzed separately.
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Study Subjects Regions examined/measures Findings Comments
Buchsbaum et al.50 12 with SPD, 11 with
SZ, 23 NCs






between those of NCs




MRI study, 1.5-T magnet;* slices
1.2 mm thick
Kwon et al.53 16 with SPD, 5 with
subthreshold SPD,†
15 with chronic SZ,
15 with first- episode




Presence of large cavum septi
pellucidi
A large cavum septi
pellucidi was more
common in subjects
with SZ than in NCs
(found in 27.3% of
subjects with SPD,
35% of those with SZ,
25% of those with
psychotic affective
disorder, and 13% of
NCs)
MRI study, 1.5-T magnet.
Appearance of cavum was
evaluated on 1.5-mm slices.
Silverman et al.83 11 with SPD (at least
4 criteria),‡ 42 with
SZ, 6 with SCA, 56
unaffected relatives,
22 NCs
VBR No difference was
seen between subjects
with SPD and those
with SZ; subjects with
SZ and SPD had
higher VBRs than did
their unaffected
relatives
CT study; slices 8.0 mm thick. One
slice used for comparison.














MRI study; 1.5-T magnet; slices 1.5
mm thick. Sample overlaps with
that of Kwon et al.53








fewer pixels in the
right mediodorsal
nucleus in subjects
with SPD than in NCs,
and fewer pixels in the
left anterior regions in
subjects with SZ than
in NCs
MRI study, 1.5-T magnet;‡ slices
1.2 mm thick. Study also included
a PET component, which showed
no difference in thalamic
metabolism between subjects with
SPD and NCs (although the
subjects with SZ had lower bilateral
metabolism in the mediodorsal
nucleus of the thalamus than did
subjects with SPD or NCs).
Warwick et al.77 32 with sex
chromosome
aneuploidies (11
with 47 XXX, 10
with 47 XYY, 10
with 47 XXY), 38
NCs§
Whole brain, R and L prefrontal
lobes, R and L temporal lobes, R
and L lentiform nuclei, R and L
caudate nuclei, R and L
thalamus, R and L
amygdalohippocampal complex,











than did female NCs,





MRI study, 1.0-T magnet. Study
based on reports of increased
incidence of schizotypal traits in
persons with sex chromosome
aneuploidies. Data for subjects
scoring high on the SIS were not
analyzed separately.
Dickey et al.55 16 with SPD, 14 NCs Lateral ventricles, temporal
horn, total CSF, cortical gray






than did NCs; a trend
was seen toward
reduced cortical gray
MRI study, 1.5-T magnet; slices 1.5
mm thick. Sample overlaps with
those of Kwon et al.53 and Dickey
et al.54
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Downhill et al.49 13 with SPD, 27 with
SZ, 30 NCs
Shape and size of corpus
callosum; volume of lateral
ventricles and anterior and
temporal horns
The genu was larger in
subjects with SPD
than in those with SZ
or NCs; a region of the
callosum just
posterior to the genu
was smaller in
subjects with SPD
than in those with SZ
or NCs; the genu and
splenium together
were smaller in
subjects with SZ than





MRI study, 1.5-T magnet;‡ slices
1.2 mm thick. Sample overlaps, in
part, with that of Buchsbaum et al.
50
Kurokawa et al.81 4 with SPD, 4 with
SZ, 7 with OCD, 1
with BDD, 14 NCs
Lateral ventricles, inferior horn,
third ventricle, VBR on 3 slices
The inferior horn was
larger and the VBR
was higher in subjects
with SPD or SZ than
in those with OCD or
NCs; the third
ventricle was larger
and the VBR was
higher in subjects
with SPD/SZ than in
those with OCD
MRI study, 1.5-T magnet; slices 1.0
mm thick; measurements were
performed on only 3 slices. All 4
subjects with SPD were treated
with neuroleptics (type
unspecified), and 2 were treated
with clomipramine. Data for
subjects with SPD were not
analyzed separately.










in subjects with SPD
or SZ than in NCs; the
mediodorsal nucleus
was smaller in
subjects with SZ than
in NCs
MRI study; 1.5-T magnet; slices 1.2
mm thick. Subsample of Hazlett et
al.51
BDD, body dysmorphic disorder; CSF, cerebrospinal fluid; CT, computerized tomography; MRI, magnetic resonance imaging; MRS, magnetic
resonance spectroscopy; NC, normal control; NOS, not otherwise specified; OCD, obsessive-compulsive disorder; PD, personality disorder; PET,
positron emission tomography; SIS, Structured Interview for Schizotypy; SPD, schizotypal personality disorder; SZ, schizophrenia; SZA,
schizoaffective disorder; VBR, ventricle:brain ratio.
*
GE Signa 5X reported; we assume this was a 1.5-T system.
†
Subjects met either three or four of the nine criteria for diagnosis.
‡
Subjects with SPD and those who met four out of nine criteria were analyzed together. How many subjects actually met criteria for SPD is unclear.
§
An unclear number of subjects scored high on the SIS.
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TABLE 2
Comparison of Morphological Abnormalities in SPD with Those in First-Episode Schizophrenia and First-
Episode Psychotic Affective Disorder
Abnormality SPD FE SZ FE AFF
Sulcal CSF increase Yes Yes No
Cortical gray matter decrease Trend Left No
Left STG gray matter decrease Yes Yes No
Posterior STG subdivisions decrease
 Heschl’s gyrus Yes Yes No
 Planum temporale No Yes No
Medial temporal lobe subdivisions decrease
 Amygdala No Yes Yes
 Hippocampus No Yes Yes
 Parahippocampus Asymmetry Yes Yes
Large cavum septi pellucidi Yes Yes Yes
AFF, psychotic affective disorder; CSF, cerebrospinal fluid; FE, first episode; SPD, schizotypal personality disorder; STG, superior temporal gyrus;
SZ, schizophrenia.
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